Relmada Therapeutics, Inc.
NASDAQ:RLMD
3.49 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -98.792 | -157.044 | -125.752 | -59.456 | -0.015 | -17.318 | -8.961 | -6.287 | -2.975 | -20.804 | -0.045 | -0.012 |
| Depreciation & Amortization
| 0 | 0 | 0.001 | 0.004 | 0 | 0.005 | 0.003 | 0.085 | 0.055 | 0.009 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 3.829 | 0.709 | -0.62 | -13.313 | 3.71 | 0 | 0 |
| Stock Based Compensation
| 43.811 | 44.195 | 40.494 | 20.777 | 0.003 | 1.214 | 0.518 | 0.704 | 1.207 | 0.797 | 0.014 | 0 |
| Change In Working Capital
| 3.08 | 10.593 | -7.865 | 10.85 | -0 | 1.505 | 0.7 | -0.248 | 1.678 | -1.12 | 0.033 | 0.004 |
| Accounts Receivables
| 0.512 | -0.426 | 0.079 | 0 | 0 | -0.169 | 0.225 | -0.001 | -0 | 0 | 0 | 0 |
| Inventory
| 0 | 0.426 | -0.079 | 0 | 0 | 0.169 | 0 | 0 | 0 | 0 | 0.003 | 0 |
| Accounts Payables
| -1.756 | 0.421 | 2.846 | 7.824 | 0 | 0.159 | 0.157 | -0.73 | 0.424 | 0.089 | 0.027 | 0.007 |
| Other Working Capital
| 4.324 | 10.172 | -10.711 | 3.026 | -0 | 1.347 | 0.543 | 0.482 | 1.253 | -1.209 | 0.003 | -0.003 |
| Other Non Cash Items
| 0.241 | -1.546 | 1.247 | 0.017 | 0 | 0.267 | 1.029 | -0.722 | -13.109 | 4.891 | 0.01 | 0 |
| Operating Cash Flow
| -51.659 | -103.802 | -91.873 | -27.809 | -0.012 | -10.498 | -6.002 | -6.466 | -13.144 | -16.227 | -0.012 | -0.008 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | -0.012 | -0.05 | -0.562 | -0.023 | -0.002 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -90.464 | -47.294 | -222.982 | -182.052 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 140.917 | 67.027 | 168.864 | 147.604 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0.05 | 0.02 | -0.054 | -0.034 | -0.08 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 50.453 | 19.734 | -54.118 | -34.448 | -0.08 | 0 | -0.012 | -0.05 | -0.562 | -0.023 | -0.002 | 0 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | 0 | 0 | -0.11 | 0 | -0.285 | -6.543 | -0.274 | -0.264 | -0.294 | 0 | 0 |
| Common Stock Issued
| 0 | 43.432 | 185.311 | 20.527 | 0 | 17.761 | 0 | 0 | 0 | 13.449 | 0.02 | 0.014 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.098 | 1.588 | 2.628 | 8.056 | 0.126 | 0 | 0 | -0 | -0 | 13.449 | 0.027 | 0 |
| Financing Cash Flow
| -0.098 | 45.02 | 187.939 | 28.473 | 0.126 | 17.475 | 6.543 | -0.274 | -0.264 | 13.156 | 0.02 | 0.014 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| -0 | 0 | 0 | 0 | -0.027 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -1.304 | -39.048 | 41.948 | -33.783 | 0.007 | 6.978 | 0.528 | -6.79 | -13.97 | -3.094 | 0.006 | 0.006 |
| Cash At End Of Period
| 4.092 | 5.396 | 44.443 | 2.495 | 0.009 | 9.217 | 2.239 | 1.711 | 8.5 | 22.47 | 0.015 | 0.009 |